Introduction Neonatal and early-life hypoglycaemia, is a frequent finding but is often non-
specific and asymptomatic, making detection and diagnosis challenging. Hypoglycaemia …

Objective Transient hyperinsulinism (THI) is the most common form of recurrent
hypoglycaemia in neonates beyond the first week of life. Although self‐resolving, treatment …

This perspective work by academic neonatal providers is written specifically for the audience
of newborn care providers and neonatologists involved in neonatal hypoglycemia …

Hypoglycemia is common in childhood with long-term neurodisability from irreversible
neuronal injury; yet the problem remains obdurately unresolved. The Research Topic series …

Introduction: Patients with congenital hyperinsulinism (HI) require constant glucose
monitoring to detect and treat recurrent and severe hypoglycemia. Historically, this has been …

Congenital hyperinsulinism (CHI) is a rare condition but is a common cause of severe and
persistent hypoglycemia in early life. Prompt recognition of CHI is critical to prevent the …

Objectives: Hypoglycemia is one of the most common presenting complaints at a pediatric
emergency department. There are many distinct causes of hypoglycemia, ranging from …

Background: Neonatal hypoglycemia is known to cause significant neuronal damage and
poor neurodevelopmental outcomes. Consensus guidelines are lacking for the management …

Evaluating the etiology of hypoglycemia is challenging in both the neonatal and pediatric
age groups. It is important to understand that the two groups have significant differences in …

Diazoxide, utilised in hyperinsulinism since the 1960s, 1 is the recommended first‐line
pharmacological therapy for children with hyperinsulinism. 2 It blocks the sulfonylurea …